India Exchange Filings

Anuh Pharma Q2 and H1 FY27 Investor Presentation

Anuh Pharma Ltd reports H1 FY27 revenue of ₹379.05 crore and PAT growth of 42.25% in investor presentation

  • H1 FY27 EBITDA was ₹36.92 crore, with a 9.74% margin versus 7.13% a year earlier.
  • Q2 FY27 revenue was ₹185.24 crore; EBITDA was ₹17.55 crore (9.47% margin) and PAT was ₹11.21 crore.
  • Presentation cites production growth, capacity expansion and plans to rebuild exports.

Original Filing

This is an automated summary of a public document. Always check the original before relying on it.